Search

Michele A Promo

from Watervliet, NY
Age ~55
Get Report
Also known as:
Michelle A Promo
Related to:
Jane Ellen Wilcox, 56Susan M Soucy, 62Timothy J Pawlik, 67Delphine PawlikJerry E Scott, 59Karen S Pawlik, 65Lorraine May Promo, 90Jane M Scott, 71Harold F Promo, 94
Connected to:
Catherine N Pronesti, 35Frank J Pronesti, 73Gina B Pronesti, 49John L Pronesti, 61Sally C Pronesti, 60Jan Proniewski, 63Anatoly Pronin, 84Vera Pronina, 36Judith C Pronk, 72Ronald R Pronk, 65

Michele Promo Phones & Addresses

  • Watervliet, NY
  • 11702 Cabot St, Cantonment, FL 32533 (229) 854-4067
  • Pensacola, FL
  • Albany, GA
  • 696 Woodrun Ct, Ballwin, MO 63021
  • Chesterfield, MO
  • Maryland Heights, MO
  • Minneapolis, MN
  • Maryland Hts, MO
  • 11702 Cabot St, Cantonment, FL 32533

Education

Degree: Graduate or professional degree

Professional Records

License Records

Michele A Promo

Address:
11702 Cabot St, Cantonment, FL
Phone:
(850) 516-4531
License #:
48491 - Active
Category:
Health Care
Issued Date:
Sep 6, 2016
Effective Date:
Sep 6, 2016
Expiration Date:
Aug 31, 2018
Type:
Clinical Laboratory Personnel

Michele A Promo

Address:
11702 Cabot St, Cantonment, FL
Phone:
(850) 516-4531
License #:
10854 - Expired
Category:
Health Care
Issued Date:
Oct 8, 2015
Effective Date:
Sep 7, 2016
Expiration Date:
Aug 31, 2016
Type:
Clinical Laboratory Trainee

Publications

Us Patents

Use Of Substituted N-Phenoxy-N-Phenyl Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

View page
US Patent:
6451823, Sep 17, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/990645
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
C07C23300
US Classification:
514351, 564184, 564300, 564310
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N-phenoxy-N-phenyl aminoalcohols. A preferred specific N-phenoxy-N-phenyl aminoalcohol is the compound:.

Use Of Substituted N,N-Disubstituted Non-Fused Heterocyclo Amino Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

View page
US Patent:
6451830, Sep 17, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/991085
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31421
US Classification:
514378, 5142268, 5142288, 514256, 514365, 514396, 514400, 544 53, 544 88, 544242, 544335, 548202, 548205, 548235, 5482731, 5482761
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N-disubstituted non-fused heterocyclo amines. A preferred specific N,N-disubstituted non-fused heterocyclo amine is the compound:.

Use Of Substituted N, N-Disubstituted Fused-Heterocyclo Amino Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

View page
US Patent:
6455519, Sep 24, 2002
Filed:
Nov 15, 2001
Appl. No.:
09/991116
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. SEarle Co. - Chicago IL
International Classification:
A61K 31536
US Classification:
51421109, 514183, 514221, 5142242, 5142305, 514249, 540468, 540473, 540552, 540569, 540573, 544 51, 544105, 544353
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N- disubstituted fused-heterocyclo amines. A preferred specific N,N-disubstituted fused-heterocyclo amine is the compound:.

Substituted N-Phenyl-N-Heteroaralkyl Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

View page
US Patent:
6458803, Oct 1, 2002
Filed:
Nov 23, 2001
Appl. No.:
09/991084
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31426
US Classification:
514311, 514241, 514242, 514256, 514277, 514357, 514365, 514400, 514406, 514415, 514427, 514438, 514471, 514245, 514275, 514313, 514352, 514370, 514377, 514380, 514398, 514407, 514426, 514447, 514472, 544182, 544215, 544242, 544335, 544374, 544378, 544194, 544213, 544326, 544336, 544332, 546176, 546329, 546334, 546159, 546304, 546306, 548205, 548214, 548235, 5483355, 5483401, 5483751, 5483761, 548491, 548561, 548562, 548193, 548198, 548233, 5483311, 5483717, 5483725, 548483, 548557, 549 74, 549 78, 549491, 549497
Abstract:
The invention relates to substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N-phenyl-N-heteroaralkyl aminoalcohols. A preferred specific N-phenyl-N-heteroaralkyl aminoalcohol is the compound:.

Use Of Substituted N,N-Disubstituted Mercapto Amino Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

View page
US Patent:
6458849, Oct 1, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/991273
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - O Fallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31145
US Classification:
514649, 514654, 514655, 514658, 564374, 564381, 564382, 564384, 564389, 564390, 564391, 564392, 564440
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl -heteroalkyamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred -heteroalkylamine compounds are substituted N,N-disubstituted mercapto amines. A preferred specific N,N-disubstituted mercapto amine is the compound:.

Use Of Substituted N, N-Bis-Phenyl Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

View page
US Patent:
6458852, Oct 1, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/991210
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31135
US Classification:
514658, 564442
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N- bis-phenyl aminoalcohols. A preferred specific N,N-bis-phenyl aminoalcohol is the compound:.

Use Of Substituted N, N-Disubstituted Reverse Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

View page
US Patent:
6462092, Oct 8, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/990811
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31133
US Classification:
514655, 514649, 514654, 514658, 564374, 564381, 564382, 564384, 564389, 564390, 564392, 564447, 564391
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N-disubstituted reverse aminoalcohols. A preferred specific N,N-disubstituted reserve aminoalcohol is the compound:.

Use Of Substituted N, N-Disubstituted Cycloalkyl Aminoalcohol Compounds For Inhibiting Cholesteryl Ester Transfer Protein Activity

View page
US Patent:
6476057, Nov 5, 2002
Filed:
Nov 14, 2001
Appl. No.:
09/990833
Inventors:
James A. Sikorski - Des Peres MO
Richard C. Durley - Chesterfield MO
Deborah A. Mischke - Defiance MO
Emily J. Reinhard - Chesterfield MO
Yvette M. Fobian - Labadie MO
Michael B. Tollefson - OFallon MO
Lijuan Wang - Wildwood MO
Margaret L. Grapperhaus - Troy IL
Brian S. Hickory - Wildwood MO
Mark A. Massa - Ballwin MO
Monica B. Norton - St. Louis MO
William F. Vernier - St. Louis MO
Barry L. Parnas - University City MO
Michele A. Promo - Chesterfield MO
Ashton T. Hamme - St. Louis MO
Dale P. Spangler - Deerfield IL
Melvin L. Rueppel - St. Louis MO
Assignee:
G.D. Searle Co. - Chicago IL
International Classification:
A61K 31133
US Classification:
514351, 514649, 514654, 514655, 514658, 546300, 564374, 564381, 564382, 564384, 564389, 564390, 564392, 564442, 564391
Abstract:
The invention relates to use of substituted polycyclic aryl and heteroaryl tertiary-heteroalkylamine compounds useful as inhibitors of cholesteryl ester transfer protein (CETP; plasma lipid transfer protein-I) and compounds, compositions and methods for treating atherosclerosis and other coronary artery diseases. Preferred tertiary-heteroalkylamine compounds are substituted N,N-disubstituted cycloalkyl aminoalcohols. A preferred specific N,N-disubstituted cycloalkyl aminoalcohol is the compound:.
Control profile
Michele A Promo from Watervliet, NY, age ~55 Get Report